000 01403 a2200481 4500
005 20250515153820.0
264 0 _c20090427
008 200904s 0 0 eng d
022 _a1546-1696
024 7 _a10.1038/nbt0109-24
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchofield, Paul N
245 0 0 _aPRIME importance of pathology expertise.
_h[electronic resource]
260 _bNature biotechnology
_cJan 2009
300 _a24-5 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aAnimals
650 0 4 _aBiotechnology
_xmethods
650 0 4 _aEurope
650 0 4 _aGenomics
650 0 4 _aHomozygote
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, Mutant Strains
650 0 4 _aMice, Transgenic
650 0 4 _aPathology
_xmethods
650 0 4 _aPhenotype
700 1 _aBrown, Steve D M
700 1 _aSundberg, John P
700 1 _aArends, Mark
700 1 _aWarren, Madhuri V
700 1 _aDubus, Pierre
700 1 _aEllender, Michele
700 1 _aFiette, Laurence
700 1 _aRozell, Bjorn
700 1 _aQuintanilla-Martinez, Leticia
700 1 _aRaspa, Marcello
700 1 _aSong, Ji-Ying
700 1 _avan der Valk, Martin
700 1 _aMcKerlie, Colin
773 0 _tNature biotechnology
_gvol. 27
_gno. 1
_gp. 24-5
856 4 0 _uhttps://doi.org/10.1038/nbt0109-24
_zAvailable from publisher's website
999 _c18580979
_d18580979